PMV Pharmaceuticals, Inc. (PMVP) AI Dilution Summary

Estimated cash was $116,179,044 as of 2026-09-02, rolled forward from $79,431,000 at 2026-06-30, against estimated monthly burn of $4,859,000. The most recent raise was a registered public offering that closed 2026-09-02, underwritten by TD Securities (USA) LLC. It sold 22,055,000 shares at $1.21 for $50,765,351 gross, or $47,000,000 net. The main source of dilution is the 41,955,000 common stock warrants at $1.21, which expire 2031-09-02.